A recent study revealed that pregnant women who receive the COVID-19 vaccine are at a reduced risk of experiencing preterm ...

The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...

The American Academy of Pediatrics updated its COVID-19 vaccination recommendations for preventing severe disease in children.

Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives ...

Pfizer's profits will fall short of Wall Street estimates next year, as it faces weaker sales of COVID products and squeezed ...

Pfizer shares fell after the company issued weaker-than-expected 2026 guidance, citing lower demand for COVID-19 products and ...

Tailoring breast cancer screening to a woman's individual cancer risk might work better than annual mammograms, researchers ...

“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” said Andrew Nixon, spokesperson for the U.S. Department of Health and Human ...

Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are ...

U.S. lawsuits against Novo Nordisk and Eli Lilly alleging patients taking weight loss drugs lost some or all of their ...

The Defense Department plans to review the records of thousands of service members who were discharged for refusing to take ...

The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.